Tender

High Tech Homecare Medicines Services - including Lot A Compounded Desferrioxamine

  • Leeds Teaching Hospitals

F02: Contract notice

Notice identifier: 2021/S 000-017843

Procurement identifier (OCID): ocds-h6vhtk-02cd21

Published 27 July 2021, 3:29pm



Section one: Contracting authority

one.1) Name and addresses

Leeds Teaching Hospitals

Moor House, 125 Moor Road

Leeds

LS10 2JQ

Contact

Mrs Amanda Stephenson

Email

amanda.stephenson1@nhs.net

Telephone

+44 1133927016

Fax

+44 1133927019

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://www.leedsteachinghospitals.com/

Buyer's address

http://www.leedsteachinghospitals.com/

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://procontract.due-north.com/Opportunities

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://procontract.due-north.com/Opportunities

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

High Tech Homecare Medicines Services - including Lot A Compounded Desferrioxamine

Reference number

DN548640

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

Framework agreement for the provision of high tech homecare medicines services (including lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.

This framework will be subject to the release of mini competitions for specific high homecare services.

Services are to be provided in line with the Royal Pharmaceutical Society Professional Standards for Homecare.

This framework agreement will be accessible to all partly or wholly publically funded bodies in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: Acute; (including their third party providers); Ambulance; Mental Health; Clinical Commissioning Groups; Health and Care Trusts; Area Teams; Local Authorities and Special Health Authorities; HSC in Northern Ireland; NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers.

Eligible participating organisations that have prior approval from the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium are:-

NHS trusts:

http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx

Clinical Commissioning Groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx

Area Teams:

http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx

Local Authorities:

https://www.lgbce.org.uk/records-and-resources/local-authorities-in-england

Special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx

HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations

NHS Scotland: http://www.scot.nhs.uk/organisations/

NHS Wales: http://www.wales.nhs.uk/ourservices/directory

For the avoidance of doubt, any successor bodies of any of the above entities shall be entitled to place Orders and shall be deemed Participating Authorities for the purposes of this Framework Agreement.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Framework agreement for the provision of high tech homecare medicines services (including lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.

This framework will be subject to the release of mini competitions for specific high homecare services.

Services are to be provided in line with the Royal Pharmaceutical Society Professional Standards for Homecare.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: Yes

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

Framework agreement with several operators

In the case of framework agreements, provide justification for any duration exceeding 4 years:

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

22 September 2021

Local time

12:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 48 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

22 September 2021

Local time

12:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

Leeds Teaching Hospitals NHS Trust

Leeds

LS10 2JQ

Country

United Kingdom